Cardiovascular Diseases (CVD)
Cardiovascular·MeSH: Cardiovascular Diseases
Prevalence
8121.9 / 100K
Incidence
682.0 / 100K/yr
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Standard Medical Therapy | Merus N.V. (MRUS) |
Frequently asked questions
How many drugs are in development for Cardiovascular Diseases (CVD)?
BioSniper tracks 1 drug in development for Cardiovascular Diseases (CVD) across 1 company.
How many clinical trials target Cardiovascular Diseases (CVD)?
There are 2 clinical trials targeting Cardiovascular Diseases (CVD) tracked by BioSniper.
What is the prevalence of Cardiovascular Diseases (CVD)?
The estimated prevalence of Cardiovascular Diseases (CVD) is approximately 8121.9 per 100,000 population.
Deep-dive into Cardiovascular Diseases (CVD)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis